Department of Laboratory Medicine, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, People's Republic of China.
Mol Biol Rep. 2012 Mar;39(3):3337-42. doi: 10.1007/s11033-011-1103-9. Epub 2011 Jun 22.
Acute coronary syndrome (ACS) is a group of clinical symptoms that results from complete or partial occlusive thrombus, which is caused by coronary an atherosclerotic plaque rupture or erosion. According to a recent study, CD4(+) CD28(-) T cells are found in atherosclerotic plaques and the peripheral circulation blood in patients with ACS, these cells play an important role in plaque ruptures. CD4(+) CD28(-) T cells are an unusual subset of helper cells, which expand and have harmful effects in ACS. In this review, we discuss the current issues on the generation of CD4(+) CD28(-) T cells and focus on their phenotypic and functional characteristics relevant to the development of cardiovascular events. Targeting the CD4(+) CD28(-) T cells subset in ACS could provide novel therapeutic means to prevent acute life-threatening coronary events.
急性冠状动脉综合征(ACS)是一组临床症状,由完全或部分阻塞性血栓引起,其由冠状动脉粥样硬化斑块破裂或侵蚀引起。最近的一项研究表明,在 ACS 患者的粥样斑块和外周循环血液中发现了 CD4(+) CD28(-) T 细胞,这些细胞在斑块破裂中发挥重要作用。CD4(+) CD28(-) T 细胞是一种异常的辅助细胞亚群,在 ACS 中会扩增并产生有害影响。在这篇综述中,我们讨论了关于 CD4(+) CD28(-) T 细胞产生的当前问题,并重点关注与心血管事件发展相关的其表型和功能特征。针对 ACS 中的 CD4(+) CD28(-) T 细胞亚群可能为预防急性危及生命的冠状动脉事件提供新的治疗手段。